Skip to main content Skip to section navigation Skip to footer
Global leader in temperature-controlled supply chain solutions for the life sciences
Cryport, Inc. Corporate Home
  • About Us
    • Company History
    • Management Team
  • Cryoport’s Business Units
  • ESG Policy
  • Investor Relations
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
    • Careers

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Company Profile
    • Executive Team
    • Contacts
    • Information Request
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Jul 16, 2018 8:30 am EDT
Cryoport Partners with World Courier to Provide Best-In-Class Logistics Platform for Global Cell and Gene Therapy Market
Jun 29, 2018 4:43 pm EDT
Cryoport Delivers Biological Samples for International Space Station; Rocket Launched Today Arrives at International Space Station on Monday
Jun 11, 2018 8:30 am EDT
Cryoport Set to Join Russell 3000 Index and Russell 2000 Index
May 03, 2018 4:10 pm EDT
Cryoport Revenue Grows 48% for First Quarter; 62% in Biopharma
Apr 23, 2018 8:30 am EDT
Cryoport to Report First Quarter 2018 Financial Results on May 3rd, 2018
Mar 06, 2018 4:10 pm EST
Cryoport Reports 56% Revenue Growth for Fiscal Year Ended December 31, 2017
Feb 20, 2018 8:30 am EST
Cryoport to Report Fourth Quarter and Fiscal Year 2017 Financial Results on March 6th, 2018
Feb 15, 2018 8:30 am EST
Cryoport to Provide DiscGenics with Cutting Edge Cold Chain Logistics Support for its Phase 1/2 Trial
Feb 05, 2018 8:30 am EST
Cryoport To Provide TiGenix With Cutting Edge Cold Chain Logistics for Clinical Trial of SEPCELL for the Treatment of Sepsis
Dec 18, 2017 8:30 am EST
The Cryoport Biotech Activity Index Decreases 7.1% In Third Quarter of 2017; While the Total Number of Clinical Trials Increases to 934 Worldwide
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Page 39
  • Next Pagearrow_forward
rss_feed News RSS
  • Accessibility statement
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
  • Sitemap
  • Cryoport Systems
  • MVE Biological Solutions
  • CRYOPDP
  • CRYOGENE
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
  • About Us
  • Cryoport’s Family of Companies
  • ESG Policy
  • Investor Relations
  • Contact Us
Cryoport, Inc. logo
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Careers
  • Newsletter
  • Manage Cookie Preferences

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

Receive Financial Updates
  • youtube
  • x
  • linkedin

Investor Contacts

Scott Eckstein
seckstein@kcsa.com

Todd Fromer
tfromer@kcsa.com

Cryoport, Inc. logo

Cryoport Inc.
112 Westwood Place, Suite 350
Brentwood, TN 37027

©2025 Cryoport Inc. All Rights Reserved.

  • youtube
  • x
  • linkedin